Home › Products › Oncology › Emvoid IV Injection
Emvoid IV Injection
Salt Composition: FOSAPREPITANT DIMEGLUMINE
- Manufacturer: TORRENT PHARMACEUTICALS LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 4GM
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store refrigerated at 2° to 8° C.
₹1090.00₹2469.56
Inclusive of all taxes
Product Introduction
Emvoid IV Injection is indicated for the treatment of nausea and vomiting. It is administered as an injection to control acute and delayed nausea and vomiting associated with cancer chemotherapy, including high-dose cisplatin (highly emetogenic chemotherapy) and moderately emetogenic cancer chemotherapy regimens. Oral contraceptives may lose efficacy during treatment with this injection. Concurrent use with warfarin significantly affects blood clotting time; patients receiving chronic warfarin therapy require monitoring before starting this injection. The injection is contraindicated in patients with known hypersensitivity. The dosage regimen includes concurrent oral dexamethasone.
Uses
High emetogenic cancer chemotherapy Moderately emetogenic cancer chemotherapy
How it works
It works by acting on the receptors responsible for nausea and vomiting, antagonizing the substances involved in the same.
How to Use
It will be administered intravenously by a healthcare professional. The reconstituted or diluted solutions should be checked for the presence of precipitate or cloudiness.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Skin blistering, peeling Low white blood cell count Anemia Anaphylactic reactions Urinary tract infection Pain in extremity Abnormal physical weakness Infection Nerve damage Common: Fatigue Diarrhea Indigestion Anemia Rash, urticaria Itching
Expert Tips
This injection should be administered only by the doctor or nurse and do not self-administer this injection. Inform the doctor if the patient has any history of allergic reactions, liver, or kidney problems, and other medication taken for different medical conditions. Consult the doctor if the patient is planning for pregnancy or breastfeeding mother before taking this medication. Avoid driving and handling heavy machinery as it causes dizziness. Patients may feel a lack of concentration and alertness.
References
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, Prokinetic and Digestant Drugs, 7th edition, 2013, 669-670.
- Merck Sharp & Dohme Corp, US Food and Drug Administration, [Revised date Feb 2016], [Accessed date 2nd April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022023s014lbl.pdf
- National Cancer Institute, [Accessed date 2nd April 2021] + https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fosaprepitant-dimeglumine
Safety Advice
Pregnancy: unsafe There are no established adverse effects of the Emvoid IV Injection during the administration of pregnancy It is advisable to take only under the specialist advice on necessary requirements. Consult your doctor about the potential risks of this medication.
Lungs: Consult your doctor It is unknown whether Emvoid IV injection is safe when administered in lung failure patients. Please consult the doctor if you have any lung problems.
Breastfeeding: unsafe Inform your physician if you are breastfeeding before taking this medicine.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.